VA GLP-1 Coverage for Veterans
Guide to Veterans Affairs coverage for GLP-1 weight loss medications. Learn about VA formulary status, eligibility, the MOVE! weight management program, and how veterans can access semaglutide and tirzepatide through the VA system.
More on Insurance & Coverage
Veteran Obesity: A Growing Crisis
Obesity rates among veterans significantly exceed the general population. Studies estimate that 40-50% of veterans enrolled in VA healthcare are obese, driven by factors unique to military service: service-connected injuries that limit physical activity, PTSD and its associated medications that promote weight gain, the transition from highly structured military fitness to civilian life, and the chronic pain conditions prevalent in veteran populations.
The VA has recognized this crisis and has been expanding weight management services. GLP-1 medications represent a significant advancement in the VA's ability to address veteran obesity, though access varies across the VA system.
VA Formulary and GLP-1 Access
The VA National Formulary determines which medications are routinely available across the VA system. GLP-1 medications on the formulary can be prescribed by any VA provider. Medications not on the national formulary may be available through individual VA medical center formularies or through non-formulary request processes.
Key Points About VA GLP-1 Access
- VA formulary status changes periodically — check current status with your VA pharmacy
- GLP-1 medications for diabetes (Ozempic, Mounjaro) may have different formulary status than weight loss versions (Wegovy, Zepbound)
- Non-formulary requests require clinical justification and may take additional time
- Individual VA medical centers may have their own prescribing protocols
- VA copays are dramatically lower than commercial pharmacy costs
The MOVE! Program
The VA's MOVE! Weight Management Program is a free, evidence-based program available at all VA medical centers. It provides:
- Individual and group weight management counseling
- Nutrition education and meal planning
- Physical activity guidance adapted for veterans with service-connected limitations
- Behavioral health support for emotional eating and PTSD-related weight management
- Telehealth MOVE! options for veterans in rural areas
Participating in MOVE! strengthens your case for pharmacotherapy by documenting structured lifestyle intervention. Many VA providers use MOVE! completion as a stepping stone to GLP-1 prescribing. Learn about how GLP-1 medications complement lifestyle programs.
Steps to Access GLP-1 Through the VA
1. Discuss with Your VA PCP
Start the conversation with your VA primary care provider. Express interest in pharmacological weight management. Document your weight history, comorbidities, and how obesity affects your daily function and quality of life.
2. Enroll in MOVE!
If you have not already, enroll in the MOVE! program. Active participation demonstrates commitment and creates documentation of lifestyle intervention. You can request pharmacotherapy while participating in MOVE! — they are complementary.
3. Request Endocrinology or Obesity Medicine Referral
If your PCP is not comfortable prescribing GLP-1 or if the medication requires specialist authorization, request a referral to VA endocrinology or weight management clinic. These specialists are more familiar with the approval process.
4. Leverage Service-Connected Conditions
If your weight gain is linked to service-connected conditions, document this connection. Medications causing weight gain, injuries preventing exercise, and mental health conditions contributing to overeating all strengthen the clinical justification.
Medical Disclaimer: This article provides general guidance on VA healthcare access and is not an official VA publication. VA formulary, coverage, and policies change periodically. Contact your local VA medical center for current information. This is not legal or benefits advice.
Frequently Asked Questions
Does the VA prescribe GLP-1 medications for weight loss?
The VA has been increasing access to GLP-1 medications for weight management. The VA National Formulary includes some GLP-1 medications, primarily for diabetes management. For weight loss specifically, availability may vary by VA medical center and may require completion of the MOVE! program first. Individual VA providers can request non-formulary medications when clinically justified.
Do I need to complete the MOVE! program before getting GLP-1?
Many VA facilities recommend or require participation in the MOVE! Weight Management Program before prescribing pharmacotherapy. MOVE! is a free, comprehensive weight management program available at all VA medical centers. Completing a structured program demonstrates commitment to lifestyle changes and may be required documentation for GLP-1 approval.
What is the copay for GLP-1 through the VA?
VA prescription copays depend on your priority group and service-connected disability status. Veterans with service-connected conditions often pay $0 for related medications. For non-service-connected prescriptions, copays are typically $5-11 per 30-day supply, significantly less than commercial insurance. Some veterans qualify for copay exemptions based on income.
Can I use community care to access GLP-1 if my VA does not prescribe it?
The VA's Community Care program allows veterans to receive care from non-VA providers when certain criteria are met (wait times, distance, specific services not available at VA). If your local VA does not prescribe GLP-1 for weight loss, you may be eligible for community care referral to a weight management specialist who can prescribe. Discuss this option with your VA primary care provider.
Is veteran obesity considered service-connected?
Obesity itself is not typically rated as a service-connected disability, but many service-connected conditions contribute to weight gain (PTSD medications, MSK injuries limiting exercise, sleep apnea). If your weight gain is secondary to a service-connected condition, this strengthens the case for VA-covered pharmacotherapy. Work with your VA provider and Veterans Service Organization to document these connections.
GLP-1 Options for Veterans
We offer accessible GLP-1 treatment that can complement or supplement VA care.
Get Started TodaySources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).